We should be Antibody testing for SARS-COV-2 Antibodies

Natural Immunity from COVID-19 infection is proving to be strong. Older people or people with pre-existing conditions with higher risk of severe COVID-19 that have not already had the COVID-19 virus and mounted an immune response SHOULD definitely consider getting the vaccine, but for those who already had the virus and developed immune response, should they? The latest data would indicate they don't need to, and that resources would be better spent immunizing those in high risk categories throughout the globe. How about for young people that have already recovered from COVID-19 infection, should they get the vaccine? Most recent data would indicate that vaccinating kids who've built their own immune response is unnecessary AND that risks from side effects likely outweigh the risks from COVID-19 in young healthy people. How about for K-12 student aged people who have not yet been infected AND do not have pre-existing conditions that impact COVID-19 severity, should they get the vaccine? Most recent data shows that this age group is not at substantial risk of death or long-COVID from COVID-19 infection and that they mount strong immune response, so diving in to vaccination is not necessary. In the United States, person freedom is paramount. Children and there parents should consider the data and make there own choice about COVID-19 vaccination. There are risks and unknowns associated with these COVID-19 vaccination and only time will tell if those risks are severe. Rushing into coercive mandated COVID-19 vaccination for children, the future of humanity, with long lives ahead of them may be a bad choice. Take a moment to breath and think before diving in, learn more about natural immune response and consider getting a serology test for SARS-COV-2 antibodies to see if you or your children already have antibodies to SARS-COV-2. Maybe the vaccine isn't the only or best choice for you or your child.

Taken from

"People who recovered from a bout of COVID-19 during one of the earlier waves of the pandemic appear to have a lower risk of contracting the Delta variant than those who got two doses of the vaccine from Pfizer and BioNTech.

The largest real-world analysis comparing natural immunity – gained from an earlier infection – to the protection provided by one of the most potent vaccines currently in use showed that reinfections were much less common.

The paper from researchers in Israel contrasts with earlier studies, which showed that immunisation offered better protection than an earlier infection, though those studies were not of the Delta variant.

The results are good news for patients who already successfully battled Covid-19, but show the challenge of relying exclusively on immunisation to move past the pandemic.

People given both doses of the Pfizer-BioNTech vaccine were almost six-fold more likely to contract a Delta infection and seven-fold more likely to have symptomatic disease than those who recovered. “This analysis showed that natural immunity affords longer lasting and stronger protection against infection, symptomatic disease and hospitalisation due to the Delta variant,” the researchers said. "

Here's a video about immune response

9 views0 comments

Recent Posts

See All

We're weren't As of October 7, the Florida Surgeon General recommends against the mRNA vaccines for males aged 18-39 years old. The Florida Health Department still recommends against their use in heal

The COVID-19 mRNA vaccines are likely killing people. And, likely killing people who were least likely to die, or to get very sick, from a COVID-19 infection. But, with the wind in big pharma's sail

Is the FDA panel using their brains. Maybe increasing scrutiny has forced their brains to work. “All the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) could agree about o